Health product recall

Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.

Last updated

Summary

Product
Quetiapine 25 mg
Issue
Health products
What to do

See instructions below. 

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Quetiapine Quetiapine 25mg DIN 02317893 Tablet Quetiapine fumarate 25 mg 35217740A

Issue

The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of Recall: Wholesalers, Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Sivem Pharmaceuticals ULC 4705 Dobrin Street, Montreal QC H4R 2P7
Published by
Health Canada
Audience
General public
Industry
Retail
Recall class
Type II
Identification number
RA-64532